Abstract In the United States the increasing number of Food and Drug Administration (FDA)-
approved, innovative, and potentially effective commercial cancer therapies pose a …

Importance Insurance status has been linked to important differences in cancer treatment
and outcomes in the US. With more than 15 million individuals gaining health insurance …

Importance In 2016, the US Centers for Medicare & Medicaid Services initiated the Oncology
Care Model (OCM), an alternative payment model designed to improve the value of care …

Since the historic approval of tisagenlecleucel for the treatment of B-cell acute lymphoblastic
leukemia in 2017, chimeric antigen receptor (CAR) T-cell therapies have altered the …

Background Implementation researchers are increasingly using economic evaluation to
explore the benefits produced by implementing evidence-based practices (EBPs) in …

Aims Moderately hypofractionated breast irradiation has been evaluated in several
prospective studies, resulting in wide acceptance of shorter treatment protocols for …

PURPOSE: To provide Standards on the basis of evidence and expert consensus for a pilot
of the Oncology Medical Home (OMH) certification program. The OMH model is a system of …

The reimbursement of expensive, innovative therapies poses a challenge to healthcare
systems. This study investigated the feasibility of managed entry agreements (MEAs) for …

Background Reimbursement systems that contribute to the cooperation and integration of
providers have become increasingly important within the healthcare sector. Reimbursement …

It has been 12 years after Porter and Teisberg published their landmark manuscript on
“Redefining Health Care.” Apart from stressing the need for a fundamental change from fee …